Asthma
Seeking participants for a clinical trial evaluating a study drug given every 12 weeks to adult participants with moderate to severe asthma.
Qualification Requirements
- Men and Women
- Ages 18 to 75 years old
- Diagnosed with asthma for at least 12 months
- Have experienced asthma exacerbations (attacks) requiring treatment within the past year
COMPENSATION UP TO: $2,375
Study Details
This clinical research study focuses on evaluating an investigational medication designed for adults living with moderate to severe asthma. The primary goal is to determine the effectiveness and safety of this study drug, which is administered (Optional: specify route if known, e.g., "intravenously" or "by injection") once every 12 weeks. This research seeks potential new options for individuals whose asthma remains challenging to control despite current therapies, potentially offering a less frequent dosing schedule.
We are seeking enrollment from adult men and women aged 18 to 75 who have been formally diagnosed with asthma for a minimum of 12 months. An important factor for eligibility is a history of experiencing asthma exacerbations (flare-ups or attacks) requiring medical intervention within the last year. This focus ensures the study includes individuals whose asthma may be classified as moderate to severe and could potentially benefit from a new therapeutic approach being investigated.